Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320
Clinical trial NCT00000885 · COMPLETED
Trial details
- NCT number
- NCT00000885
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.